Medical control of abdominal aortic aneurysm expansion rate

Free article

Comment

J Schneiderman et al. J Vasc Surg. 1996 Aug.

Free article

. 1996 Aug;24(2):297.

doi: 10.1016/s0741-5214(96)70109-x.

No abstract available

Comment on

Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity.
Moursi MM, Beebe HG, Messina LM, Welling TH, Stanley JC. Moursi MM, et al. J Vasc Surg. 1995 May;21(5):792-9; discussion 799-800. doi: 10.1016/s0741-5214(05)80010-2. J Vasc Surg. 1995. PMID: 7769737

Design of a trial to evaluate the effect of propranolol upon abdominal aortic aneurysm expansion.
Ricci MA, Pilcher DB, McBride R. Ricci MA, et al. Ann N Y Acad Sci. 1996 Nov 18;800:252-3. doi: 10.1111/j.1749-6632.1996.tb33321.x. Ann N Y Acad Sci. 1996. PMID: 8959004 Clinical Trial. No abstract available.
Expansion rates of small abdominal aortic aneurysms.
Englund R, Hudson P, Hanel K, Stanton A. Englund R, et al. Aust N Z J Surg. 1998 Jan;68(1):21-4. doi: 10.1111/j.1445-2197.1998.tb04630.x. Aust N Z J Surg. 1998. PMID: 9440450
Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade.
Gadowski GR, Pilcher DB, Ricci MA. Gadowski GR, et al. J Vasc Surg. 1994 Apr;19(4):727-31. doi: 10.1016/s0741-5214(94)70048-6. J Vasc Surg. 1994. PMID: 7909340
Variables that affect the expansion rate and rupture of abdominal aortic aneurysms.
Cronenwett JL. Cronenwett JL. Ann N Y Acad Sci. 1996 Nov 18;800:56-67. doi: 10.1111/j.1749-6632.1996.tb33298.x. Ann N Y Acad Sci. 1996. PMID: 8958982 Review. No abstract available.
[Optimizing medical treatment of abdominal aortic aneurysm: Interest of vascular centers].
Madika AL, Mounier-Vehier C, Azzaoui R. Madika AL, et al. Presse Med. 2018 Feb;47(2):161-166. doi: 10.1016/j.lpm.2018.01.019. Epub 2018 Feb 28. Presse Med. 2018. PMID: 29499996 Review. French.